Development and validation of a COVID-19 vaccine hesitancy scale for adults in the United States
Authors:
- 31 August 2022
- Vol. 40 (40) , 5764-5768
Abstract
No abstract availableKeywords
Funding Information
- Novartis
- National Institutes of Health (UL1TR001420)
- National Center for Advancing Translational Sciences
- National Psoriasis Foundation (IRB00072726)
- Wake Forest Clinical and Translational Science Institute, Wake Forest School of Medicine
- Galderma
- Merck
This publication has 14 references indexed in Scilit:
- Factors Associated with Willingness to be Vaccinated Against COVID-19 in a Large Convenience SampleJournal of Community Health, 2021
- Sustained COVID-19 vaccine willingness after safety concerns over the Oxford-AstraZeneca vaccine.2021
- Trust in Doctors, Positive Attitudes, and Vaccination Behavior: The Role of Doctor–Patient Communication in H1N1 VaccinationHealth Communication, 2021
- COVID-19 Vaccination Hesitancy in the United States: A Rapid National AssessmentJournal of Community Health, 2021
- Factors Associated With US Adults’ Likelihood of Accepting COVID-19 VaccinationJAMA Network Open, 2020
- COVID-19 conspiracy beliefs, health behaviors, and policy supportTranslational Behavioral Medicine, 2020
- Assessing vaccine hesitancy in the UK population using a generalized vaccine hesitancy survey instrumentVaccine, 2019
- Measuring Belief in Conspiracy Theories: The Generic Conspiracist Beliefs ScaleFrontiers in Psychology, 2013
- Amazon's Mechanical TurkPerspectives on Psychological Science, 2011
- Development of the Trust in Physician Scale: A Measure to Assess Interpersonal Trust in Patient-Physician RelationshipsPsychological Reports, 1990